337 related articles for article (PubMed ID: 24976932)
1. Neuroimaging in Huntington's disease.
Niccolini F; Politis M
World J Radiol; 2014 Jun; 6(6):301-12. PubMed ID: 24976932
[TBL] [Abstract][Full Text] [Related]
2. Molecular Imaging Markers to Track Huntington's Disease Pathology.
Wilson H; De Micco R; Niccolini F; Politis M
Front Neurol; 2017; 8():11. PubMed ID: 28194132
[TBL] [Abstract][Full Text] [Related]
3. Structural Magnetic Resonance Imaging in Huntington's Disease.
Wilson H; Dervenoulas G; Politis M
Int Rev Neurobiol; 2018; 142():335-380. PubMed ID: 30409258
[TBL] [Abstract][Full Text] [Related]
4. Current status of PET imaging in Huntington's disease.
Pagano G; Niccolini F; Politis M
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1171-82. PubMed ID: 26899245
[TBL] [Abstract][Full Text] [Related]
5. Novel Imaging Biomarkers for Huntington's Disease and Other Hereditary Choreas.
Fazio P; Paucar M; Svenningsson P; Varrone A
Curr Neurol Neurosci Rep; 2018 Oct; 18(12):85. PubMed ID: 30291526
[TBL] [Abstract][Full Text] [Related]
6. Molecular Imaging in Huntington's Disease.
Wilson H; Politis M
Int Rev Neurobiol; 2018; 142():289-333. PubMed ID: 30409256
[TBL] [Abstract][Full Text] [Related]
7. PET Imaging in Huntington's Disease.
Roussakis AA; Piccini P
J Huntingtons Dis; 2015; 4(4):287-96. PubMed ID: 26683130
[TBL] [Abstract][Full Text] [Related]
8. Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease.
Niccolini F; Haider S; Reis Marques T; Muhlert N; Tziortzi AC; Searle GE; Natesan S; Piccini P; Kapur S; Rabiner EA; Gunn RN; Tabrizi SJ; Politis M
Brain; 2015 Oct; 138(Pt 10):3016-29. PubMed ID: 26198591
[TBL] [Abstract][Full Text] [Related]
9. Early grey matter changes in structural covariance networks in Huntington's disease.
Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of Huntington's Disease: An Emphasis on Molecular Pathways and Prevention by Natural Remedies.
Irfan Z; Khanam S; Karmakar V; Firdous SM; El Khier BSIA; Khan I; Rehman MU; Khan A
Brain Sci; 2022 Oct; 12(10):. PubMed ID: 36291322
[TBL] [Abstract][Full Text] [Related]
11. Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study.
Politis M; Pavese N; Tai YF; Kiferle L; Mason SL; Brooks DJ; Tabrizi SJ; Barker RA; Piccini P
Hum Brain Mapp; 2011 Feb; 32(2):258-70. PubMed ID: 21229614
[TBL] [Abstract][Full Text] [Related]
12. Hybrid 2-[18F] FDG PET/MRI in premanifest Huntington's disease gene-expansion carriers: The significance of partial volume correction.
Hellem MNN; Vinther-Jensen T; Anderberg L; Budtz-Jørgensen E; Hjermind LE; Larsen VA; Nielsen JE; Law I
PLoS One; 2021; 16(6):e0252683. PubMed ID: 34115782
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Multidimensional Brain Imaging in Huntington's Disease Animal Models.
Flament J; Hantraye P; Valette J
Methods Mol Biol; 2018; 1780():285-301. PubMed ID: 29856025
[TBL] [Abstract][Full Text] [Related]
14. Striatal hypometabolism in premanifest and manifest Huntington's disease patients.
López-Mora DA; Camacho V; Pérez-Pérez J; Martínez-Horta S; Fernández A; Sampedro F; Montes A; Lozano-Martínez GA; Gómez-Anson B; Kulisevsky J; Carrió I
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2183-2189. PubMed ID: 27349245
[TBL] [Abstract][Full Text] [Related]
15. Cortical atrophic-hypometabolic dissociation in the transition from premanifest to early-stage Huntington's disease.
Sampedro F; Martínez-Horta S; Perez-Perez J; Horta-Barba A; Lopez-Mora DA; Camacho V; Fernández-León A; Gomez-Anson B; Carrió I; Kulisevsky J
Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1111-1116. PubMed ID: 30627816
[TBL] [Abstract][Full Text] [Related]
16. Metabolic network as a progression biomarker of premanifest Huntington's disease.
Tang CC; Feigin A; Ma Y; Habeck C; Paulsen JS; Leenders KL; Teune LK; van Oostrom JC; Guttman M; Dhawan V; Eidelberg D
J Clin Invest; 2013 Sep; 123(9):4076-88. PubMed ID: 23985564
[TBL] [Abstract][Full Text] [Related]
17. Basal ganglia-cortical structural connectivity in Huntington's disease.
Novak MJ; Seunarine KK; Gibbard CR; McColgan P; Draganski B; Friston K; Clark CA; Tabrizi SJ
Hum Brain Mapp; 2015 May; 36(5):1728-40. PubMed ID: 25640796
[TBL] [Abstract][Full Text] [Related]
18. Genetic modifiers of Huntington's disease.
Gusella JF; MacDonald ME; Lee JM
Mov Disord; 2014 Sep; 29(11):1359-65. PubMed ID: 25154728
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]